Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

9 Meters Biopharma Inc (NMTR)

9 Meters Biopharma Inc (NMTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

9 Meters Biopharma Inc 4509 CREEDMOOR ROAD SUITE 201 RALEIGH NC 27612 USA

www.9meters.com P: 919-275-1933

Description:

9 Meters Biopharma, Inc. is a rare, orphan and unmet needs focused GI company. It's advancing NM-002, a proprietary long-acting GLP-1 agonist into Phase 2 trial for Short Bowel Syndrome, a rare, orphan disease, as well as larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom. 9 Meters Biopharma Inc., formerly known as Innovate Bioph, is based in Raleigh, United States.

Key Statistics

Overview:

Market Capitalization, $K 1,035
Enterprise Value, $K -11,615
Shares Outstanding, K 14,336
Annual Sales, $ 0 K
Annual Net Income, $ -43,770 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -13,870 K
60-Month Beta 1.36
% of Insider Shareholders 2.40%
% of Institutional Shareholders 22.34%
Float, K 13,992
% Float 97.60%
Short Volume Ratio 0.50

Growth:

1-Year Return -98.43%
3-Year Return -99.24%
5-Year Return 0.00%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.02 on 05/15/23
Next Earnings Date 08/21/23
Earnings Per Share ttm -3.46
EPS Growth vs. Prev Qtr -10.87%
EPS Growth vs. Prev Year -27.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 10/18/22

NMTR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -584.97%
Return-on-Assets % -159.45%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.44
Interest Coverage -15.39
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar